We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Brady Corp
BRC
$4.44B
| $3.67M | 0.01% |
94,983
+26,515
| +39% | +$998K |
|
|
BLD
1202
DELISTED
TopBuild
BLD
| $3.66M | 0.01% |
77,811
+20,700
| +36% | +$840K |
|
1203
Kemper
KMPR
$1.67B
| $3.65M | 0.01% |
91,473
+2,723
| +3% | +$116K |
|
1204
Boyd Gaming
BYD
$6.32B
| $3.65M | 0.01% |
165,686
+46,169
| +39% | +$938K |
|
1205
iShares Russell Mid-Cap Growth ETF
IWP
$19.8B
| $3.64M | 0.01% |
70,240
+21,190
| +43% | +$1.08M |
|
1206
First Solar
FSLR
$22.7B
| $3.64M | 0.01% |
134,408
+4,753
| +4% | +$156K |
|
|
ALR
1207
DELISTED
Alere Inc
ALR
| $3.63M | 0.01% |
91,438
+5,479
| +6% | +$214K |
|
1208
Methode Electronics
MEI
$496M
| $3.62M | 0.01% |
79,370
+20,462
| +35% | +$872K |
|
1209
Northwest Natural Holdings
NWN
$2.06B
| $3.61M | 0.01% |
61,153
+16,304
| +36% | +$962K |
|
|
RICE
1210
DELISTED
Rice Energy Inc.
RICE
| $3.58M | 0.01% |
151,189
+6,324
| +4% | +$131K |
|
|
LTXB
1211
DELISTED
LegacyTexas Financial Group Inc
LTXB
| $3.58M | 0.01% |
89,761
+21,355
| +31% | +$890K |
|
1212
Acadia Healthcare
ACHC
$2.76B
| $3.58M | 0.01% |
82,023
+4,435
| +6% | +$180K |
|
1213
HealthEquity
HQY
$8.41B
| $3.57M | 0.01% |
84,000
+25,432
| +43% | +$1.13M |
|
1214
Stepan Co
SCL
$1.46B
| $3.56M | 0.01% |
45,231
+11,006
| +32% | +$859K |
|
1215
Knowles
KN
$3.13B
| $3.56M | 0.01% |
187,966
+5,240
| +3% | +$95.8K |
|
1216
FTI Consulting
FCN
$4.4B
| $3.56M | 0.01% |
86,460
+908
| +1% | +$37.7K |
|
1217
RH
RH
$3.13B
| $3.56M | 0.01% |
76,945
+474
| +0.6% | +$14.7K |
|
1218
Skywest
SKYW
$4.24B
| $3.56M | 0.01% |
103,909
+28,054
| +37% | +$1M |
|
1219
First Financial Bancorp
FFBC
$3.55B
| $3.55M | 0.01% |
129,434
+34,141
| +36% | +$950K |
|
|
MGLN
1220
DELISTED
Magellan Health Services, Inc.
MGLN
| $3.53M | 0.01% |
51,138
+12,803
| +33% | +$935K |
|
1221
Ameris Bancorp
ABCB
$5.85B
| $3.53M | 0.01% |
76,496
+20,631
| +37% | +$943K |
|
1222
Choice Hotels
CHH
$5.07B
| $3.53M | 0.01% |
56,323
+8,736
| +18% | +$514K |
|
1223
California Water Service
CWT
$3B
| $3.52M | 0.01% |
98,334
+26,606
| +37% | +$921K |
|
|
CBM
1224
DELISTED
Cambrex Corporation
CBM
| $3.51M | 0.01% |
63,827
+18,427
| +41% | +$984K |
|
1225
Adeia
ADEA
$2.94B
| $3.51M | 0.01% |
391,041
+103,999
| +36% | +$1.12M |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.